ArticleArthritis research & therapy2023

TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma.

Ilari Mäki-Opas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.